title: [Diastolic dysfunction].
authors.forename: V I
authors.initials: VI
authors.lastname: Kapel'ko
mesh_terms: D058671:Adrenergic beta-1 Receptor Antagonists / Q000493:pharmacokinetics*; D000818:Animals; D000975:Antioxidants / Q000493:pharmacokinetics*; D002121:Calcium Channel Blockers / Q000493:pharmacokinetics*; D020013:Calcium Signaling; D064211:Connectin; D054144:Heart Failure, Diastolic / Q000150:complications / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D054143:Heart Failure, Systolic / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D006352:Heart Ventricles / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000150:complications / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D009124:Muscle Proteins / Q000378:metabolism; D009200:Myocardial Contraction / Q000187:drug effects*; D020030:Nitric Oxide Donors / Q000493:pharmacokinetics*; D052248:Nitric Oxide Synthase Type I / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects; D011494:Protein Kinases / Q000378:metabolism; D051381:Rats; D012518:Sarcomeres / Q000378:metabolism / Q000648:ultrastructure
chemical_list: D058671:Adrenergic beta-1 Receptor Antagonists; D000975:Antioxidants; D002121:Calcium Channel Blockers; D064211:Connectin; D009124:Muscle Proteins; D020030:Nitric Oxide Donors; C577285:TTN protein, human; D052248:Nitric Oxide Synthase Type I; D011494:Protein Kinases